Skip to Main Content

Aligos Therapeutics, Inc. Common Stock

ALGS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
ALGS Income Statement
ALGS Balance Sheet
ALGS Cash Flow

Recent trades of ALGS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ALGS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ALGS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ALGS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ALGS's directors and management

Government lobbying spending instances

  • $110,000 Jul 20, 2023 Issue: Labor Issues/Antitrust/Workplace

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Oct. 29, 2024
  • Patent Title: Anti-viral compounds Aug. 20, 2024
  • Patent Title: Methods and compositions for targeting pd-l1 Jun. 25, 2024
  • Patent Title: Bicyclic compounds Apr. 16, 2024
  • Patent Title: Bicyclic compounds Apr. 09, 2024
  • Patent Title: Anti-viral compounds Apr. 09, 2024
  • Patent Title: Methods and compositions for targeting pd-l1 Mar. 26, 2024
  • Patent Title: Bicyclic pyridazinones and methods of use thereof Jan. 02, 2024
  • Patent Title: Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis b Dec. 19, 2023
  • Patent Title: Modulators of thr-β and methods of use thereof Dec. 12, 2023
  • Patent Title: Tricyclic compounds Nov. 21, 2023
  • Patent Title: Oxindoles and methods of use thereof Oct. 24, 2023
  • Patent Title: Modified cyclic dinucleoside compounds as sting modulators Oct. 17, 2023
  • Patent Title: 2-pyridones and methods of use thereof Oct. 17, 2023
  • Patent Title: Pyrrole compounds Oct. 03, 2023
  • Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
  • Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
  • Patent Title: Methods of reducing virus molecule levels Mar. 28, 2023
  • Patent Title: Bicyclic and tricyclic compounds Feb. 28, 2023
  • Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Jan. 10, 2023
  • Patent Title: Modified gapmer oligonucleotides and methods of use Oct. 11, 2022
  • Patent Title: Heterocyclic compounds Oct. 11, 2022
  • Patent Title: Compounds targeting prmt5 Dec. 14, 2021
  • Patent Title: Pyrrole compounds Dec. 07, 2021
  • Patent Title: S-antigen transport inhibiting oligonucleotide polymers and methods Nov. 09, 2021
  • Patent Title: Tricyclic compounds Oct. 05, 2021
  • Patent Title: Modulators of thr-β and methods of use thereof Aug. 17, 2021
  • Patent Title: Bicyclic sulfonamides Jun. 15, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of ALGS in WallStreetBets Daily Discussion

ALGS News

Recent insights relating to ALGS

CNBC Recommendations

Recent picks made for ALGS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALGS

ALGS Top Shareholders
Shareholder
Shares Held
ALGS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ALGS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ALGS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top